FDA Drug · D-0768-2026

CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION, USP, 75 mg/5 mL, Rx Only, 100 mL, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-603-51

Class II · Ongoing

Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.

Affected lots / codes — check yours against thisLot #: 2411550, Exp. 2026/NOV.

Recalling firm: Heritage Pharmaceuticals Inc, East Brunswick, NJ
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: —
Distribution: Nationwide within the U.S
Recall initiated: July 30, 2026
Classified: August 14, 2026
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0768-2026%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →